CHICAGO -- Intracavernosal platelet-rich plasma (PRP) injections were no better than placebo for treating mild-to-moderate erectile dysfunction, a randomized, single-center trial found. At 1 month ...

NAME a health concern and there’s probably a supplement for it – and that goes for issues in the bedroom too. Most men will ...

In continuation of last week’s essay, Type 2 is the most common type of ED in men under 45. It is also the only type that has ...

Eroxon, a topical gel intended to treat erectile dysfunction, may soon be available in the United States. The Food and Drug Administration authorized the marketing of the product as a medical device ...

While no one wants to experience erectile dysfunction, commonly referred to as ED, many men - and their partners - are often relieved to learn that the condition is far more common than many people ...